enVVeno Medical Corp's activist stake is now 0.00% after Braeden Lichti sold all previously owned common stock on September 11, 2026, and Northstrive Fund II LP completed its sales by September 14. Investors now have a final exit position from both reporting persons, with neither holding NVNO shares.
Key Highlights
- Northstrive Fund II LP sold its remaining enVVeno Medical Corp shares between September 11 and September 14, 2026.
- Both reporting persons signed the final amendment on September 15, 2026.
- Activist ownership stake in enVVeno Medical Corp fell to 0.00%.
- Braeden Lichti sold all previously owned common stock on September 11, 2026.
EnVVeno Medical Corp (NASDAQ: NVNO) now has a reported activist ownership stake of 0.00%, after Braeden Lichti sold all previously owned common stock and Northstrive Fund II LP completed its exit. Lichti’s sale occurred on September 11, 2026, while Northstrive Fund II LP sold its shares between September 11 and September 14. The final amendment identifies both parties as exit reporting persons, with neither retaining common stock.
0.00% Activist Stake Ends
Northstrive Fund II LP and Lichti jointly reported their ownership of enVVeno Medical Corp’s common stock, which has a Par Value of $0.00001 per share. Lichti is the manager of Northstrive Fund II LP, a Delaware limited Partnership principally engaged in investments in private and public securities. Lichti previously used personal funds to acquire his shares, while Northstrive Fund II LP used Working Capital for its purchases. The amendment was signed on September 15, 2026, by Lichti individually and as manager of Northstrive Fund II LP.
FAQs
Q: What happened to enVVeno Medical Corp’s activist stake?
A: The activist stake fell to 0.00%. Braeden Lichti and Northstrive Fund II LP sold all their previously owned enVVeno Medical Corp common stock.
Q: When did Braeden Lichti sell NVNO shares?
A: Braeden Lichti sold all previously owned common stock on September 11, 2026. He no longer owns shares of enVVeno Medical Corp.
Q: Who were the reporting persons in the enVVeno Medical Schedule 13D?
A: The reporting persons were Braeden Lichti and Northstrive Fund II LP. Lichti served as the fund’s manager and signed for both parties.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.